Leaderboards/cutaneous lymphoproliferative disorders research

cutaneous lymphoproliferative disorders research

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Rein Willemze
Leiden University Medical Center
99
2
Marion Wobser
Universitätsklinikum Würzburg
90
3
Tiffany Hangse
Western Michigan University
80
4
Н. В. Александрова
Onze Lieve Vrouwziekenhuis Hospital
60
5
et al.
Unknown
40
6
Muhammad Saad Hamid
Piedmont Cancer Institute
30
7
Shalini Vemula
Unknown
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Christopher P. Fox
University of Nottingham
99
2
Pietro Quaglino
Department of Medical Sciences
88
3
Elise A. Olsen
Duke University Hospital
75
4
El bakali E
Unknown
63
5
Erika Morsia
Marche Polytechnic University
50
6
P. Harkins
St. James's Hospital
38
7
Mercedes Debernardi
Consejo Nacional de Investigaciones Científicas y Técnicas
25
8
Vamsidhar Veeranki
Sanjay Gandhi Post Graduate Institute of Medical Sciences
13

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Marco Santucci
Okayama University
99
2
Marco Ladetto
University of Turin
90
3
Dennis D. Weisenburger
University of Nebraska Medical Center
80
4
Emilio Berti
University of Milan
70
5
Eric J. Allenspach
University of Washington
70
6
Lorraine C. Racusen
Johns Hopkins University
60
7
Wolfram Sterry
Charité - Universitätsmedizin Berlin
50
8
Katleen Devue
Onze Lieve Vrouwziekenhuis Hospital
50
9
Eric C. Vonderheid
Harvard University Press
40
10
Vincent Liu
University of Iowa Hospitals and Clinics
30

All-Time Leaders Papers

1
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
American Journal of Transplantation|2003
1.1k cit.
2
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2015
920 cit.
3
ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project
Blood|2008
851 cit.
4
Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP
Clinical Cancer Research|2021
42 cit.

Reagents for cutaneous lymphoproliferative disorders research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

Keratin 20 (D9Z1Z) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 555 Conjugate)

#95998$458
View Evidence →Agilent/Dako

Mutated melanoma-associated antigen 1

#M7259
View Evidence →Cell Signaling Technology

IKK epsilon (D61F9) Rabbit Monoclonal Antibody

#3416$159
View Evidence →

🌟 All-Time

Most validated

New England Biolabs

NEBNext Ultra II DNA Library Prep Kit for Illumina

Cited in 6 papers
#E7645S
View Evidence →Agilent/Dako

CD79______??,

#M7050
View Evidence →Cell Signaling Technology

Phospho-Stat4 (Tyr693) Antibody

#5267$362
View Evidence →